News
3h
Zacks Investment Research on MSNTEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Recently, Tempus AI TEM updated its sales guidance for 2025. It did so for the second time within six months, backed by a strong second-quarter performance. Full-year revenues are now expected to be ...
Nvidia is far and away the main supplier of AI-focused GPUs, with an estimated market share of over 90%. This virtual monopoly has paid off for Nvidia (quite literally), increasing its revenue from $8 ...
The stock soared after investors heard that update. Exponential revenue increases are being driven by its burgeoning AI infrastructure services. Just as importantly for investors, Nebius has a solid ...
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...
Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.
In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Tempus AI, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $60.87. Take ...
In a report released on August 8, Subbu Nambi from Guggenheim reiterated a Buy rating on Tempus AI, Inc. Class A, with a price target of $75.00. The company’s shares closed last Friday at $60.87.
Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...
Alphabet, UnitedHealth Group, Salesforce, Oracle, ServiceNow, Palo Alto Networks, and Tempus AI are the seven Healthcare ...
U.S. President Donald Trump launched a scathing attack on former House speaker Nancy Pelosi and her husband Paul Pelosi, on ...
4d
TipRanks on MSNTEM Earnings: Tempus AI Stock (TEM) ‘Hitting its Stride’ on Soaring AI Drug Demand
Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing demand. Forecast Busting ...
The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results